Publication:
Terbutaline pump maintenance therapy after threatened preterm labour for reducing adverse neonatal outcomes

dc.contributor.authorSaifon Chawanpaiboonen_US
dc.contributor.authorMalinee Laopaiboonen_US
dc.contributor.authorPisake Lumbiganonen_US
dc.contributor.authorUssanee S. Sangkomkamhangen_US
dc.contributor.authorTherese Dowswellen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherKhon Kaen Universityen_US
dc.contributor.otherKhon Kaen Regional Hospitalen_US
dc.contributor.otherUniversity of Liverpoolen_US
dc.date.accessioned2018-10-19T05:13:54Z
dc.date.available2018-10-19T05:13:54Z
dc.date.issued2013-10-24en_US
dc.description.abstract© 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of continuous low-dose subcutaneous terbutaline infusion maintenance therapy after threatened preterm labour for reducing adverse neonatal outcomes. Safety and adverse maternal and neonatal outcomes will also be determined.en_US
dc.identifier.citationCochrane Database of Systematic Reviews. Vol.2013, No.10 (2013)en_US
dc.identifier.doi10.1002/14651858.CD010800en_US
dc.identifier.issn1469493Xen_US
dc.identifier.other2-s2.0-85040458376en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/32106
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85040458376&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleTerbutaline pump maintenance therapy after threatened preterm labour for reducing adverse neonatal outcomesen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85040458376&origin=inwarden_US

Files

Collections